Dale J. Christensen - Concepedia

Author

Dale J. Christensen

Also Known As

D Christensen, D J Christensen, D. J. Christensen, D.J. Christensen, Dale Christensen, Dale J Christensen, Dale J. CHRISTENSEN, Dale J. Christensen

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Duke Medical Center Oncotide Pharmaceuticals (United States)Duke University Hospital Oregon Health & Science University The University of Texas at Austin

About

Dale J. Christensen is an author at Duke Medical Center specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	1.4K
2	Natural Sciences	4	4	208
3	Engineering	2	2	74
4	Social Sciences	1	1	50
5	Allergy	1	1	51

Dale J. Christensen

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Estrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β Lisa A. Paige, Dale J. Christensen, Hanne Grøn, Proceedings of the National Academy of Sciences	1999	412
Peptide Antagonists of the Human Estrogen Receptor John D. Norris, Lisa A. Paige, Dale J. Christensen, Science Breast OncologySignal TransductionTamoxifen-refractory Breast CancersMedicineEstrogen Receptor Alpha	1999	377
Comparative Analyses of Mechanistic Differences Among Antiestrogens1 Ashini L. Wijayaratne, Susan C. Nagel, Lisa A. Paige, Endocrinology Breast OncologyChemoprevention StrategyDifferent AntiestrogenEndocrine-related CancerMedicine	1999	245
Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer Mahnaz Janghorban, Amy Farrell, Brittany L. Allen-Petersen, Proceedings of the National Academy of Sciences	2014	186
Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy Christopher Switzer, Robert Y.S. Cheng, T M Vitek, Oncogene Cancer TherapyMulti-pathway StrategyOncologyOncogenic AgentMedicine	2011	169
SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target Dale J. Christensen, Youwei Chen, Jessica Oddo, Blood	2011	128
Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia Anupriya Agarwal, Ryan J. MacKenzie, Raffaella Pippa, Clinical Cancer Research	2014	123
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing Sawittree Sahakijpijarn, Chaeho Moon, John J. Koleng, Pharmaceutics	2020	122
Apolipoprotein E and Peptide Mimetics Modulate Inflammation by Binding the SET Protein and Activating Protein Phosphatase 2A Dale J. Christensen, Nobutaka Ohkubo, Jessica Oddo, The Journal of Immunology Lipid PeroxidationSet ProteinImmunologyCell DeathOxidative Stress	2011	119
Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer Amy Farrell, Brittany L. Allen-Petersen, Colin J. Daniel, Molecular Cancer Research	2014	110

Page 1